By Tracy Qu
Shares of ClouDr Group rose sharply in Hong Kong after the Chinese medical software provider said it will integrate AI firm DeepSeek's model into its core product.
The stock rose 12% to HK$1.81 in Thursday morning trade, extending year-to-date gains to 52.5% and outperforming the benchmark Hang Seng Index, which was up 0.1%.
The company, which provides digital solutions for managing chronic conditions, said it has integrated the DeepSeek-R1 model with its medical artificial-intelligence system ClouDr Brain to improve data analysis. This is expected to help hospitals and pharmacies enhance the use of ClouDr's AI system to manage patients with chronic medical conditions, it said.
"The integration of the DeepSeek-R1 model in ClouDr Brain combines advanced data analysis and AI technology to provide precise decision-making support for chronic disease management through big data analysis and machine learning algorithms," the company said.
Founded in 2014, ClouDr specializes in healthcare digitalization.
DeepSeek's R1 large-language model made waves when it was released in January for purportedly achieving high efficiency with lower-tech chips at cheaper costs. OpenAI CEO Sam Altman has called it "an impressive model."
Write to Tracy Qu at tracy.qu@wsj.com
(END) Dow Jones Newswires
February 05, 2025 22:15 ET (03:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。